throbber
Trials@uspto.gov
`571-272-7822
`
`
`
`
`
`
`
`Paper 42
`Date: September 19, 2016
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner,
`
`v.
`
`RESEARCH CORPORATION TECHNOLOGIES, INC.,
`Patent Owner.
`____________
`
`Case IPR2016-00204
`Patent RE38,551 E
`____________
`
`
`
`Before FRANCISCO C. PRATS, JACQUELINE WRIGHT BONILLA, and
`CHRISTOPHER G. PAULRAJ, Administrative Patent Judges.
`
`BONILLA, Administrative Patent Judge.
`
`
`
`
`DECISION
`Denying Petitioner’s Motion to Consolidate
`35 U.S.C. § 315(d) and 37 C.F.R. § 42.122(a)
`
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`I.
`
`Introduction
`
`As authorized by our Order (Paper 27), Argentum
`
`Pharmaceuticals LLC (“Petitioner”) filed a Motion to Consolidate this
`
`inter partes review (“IPR”) proceeding with pending ex parte reexamination
`
`Control No. 90/013,709, also requested by Petitioner concerning the same
`
`challenged patent at issue here, U.S. Patent No. RE38,551 (“the
`
`’551patent”). Paper 30 (Petitioner’s Motion to Consolidate Reexamination
`
`with Inter Partes Review; “Motion to Consolidate” or “Motion”).
`
`As also authorized by the same Order (Paper 27), Research
`
`Corporation Technologies, Inc. (“Patent Owner”) filed an Opposition to the
`
`Motion. Paper 32 (Patent Owner’s Opposition to Petitioner’s Motion to
`
`Consolidate Reexamination with Inter Partes Review, “Opposition”).
`
`II. DISCUSSION
`
`As acknowledged by both parties, we have discretion to, among other
`
`things, consolidate an IPR with another proceeding before the Office, such
`
`as a reexamination, if both proceedings involve the same patent. Motion 3
`
`(citing 35 U.S.C. § 315(d); 37 C.F.R § 42.122(a)); Opposition 6. As part of
`
`that discretion, we are not prohibited from allowing multiple proceedings
`
`involving the same patent to continue separately before the Office.
`
`As stated in Petitioner’s Motion, Petitioner’s request for the
`
`reexamination raised two grounds of rejection of claims 1–13 of the
`
`’551 patent under the doctrine of obviousness-type double patenting
`
`(“OTDP”) based on U.S. Pat. No. 5,654,301 (“the ’301 patent”),1 a reference
`
`
`1 Kohn et al., U.S. Patent No. 5,654,301, issued on Aug. 5, 1997 (“the
`’301 patent”) (Ex. 1019).
`
`
`
`2
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`not raised in a ground at issue in the IPR (Paper 19, 3–4, 23–24), in
`
`combination with other art raised in grounds in the Petition in this IPR.
`
`Specifically, Petitioner proposed two OTDP grounds of rejection based on
`
`the ’301 patent, in view of the ’729 patent2 and Kohn 19913 in the first
`
`ground, and in view of the ’729 patent and the LeGall thesis4 in the second
`
`ground. Motion 1–2; Paper 27, 2–3. The Central Reexamination Unit
`
`(“CRU”) granted the request on June 16, 2016. Motion 2.
`
`By contrast, this panel instituted the IPR based on two different
`
`grounds raised in the Petition (Paper 2), i.e., that (1) claims 1–9 of the
`
`’551 patent would have been obvious over Kohn 1991 and Silverman,5 and
`
`(2) claims 10–13 would have been obvious over Kohn 1991, Silverman, and
`
`the ’729 patent. Paper 20 (Decision to Institute), 23–24. In this IPR, we
`
`declined to institute review based on any ground raised by Petitioner that
`
`relied on the LeGall thesis. Id. at 8–12.
`
`Thus, the IPR and reexamination proceedings address different issues
`
`(obviousness under 35 U.S.C. § 103(a) versus the judicially created doctrine
`
`of OTDP), as well as different combinations of primary references (Kohn
`
`
`2 Kohn et al., U.S. Patent No. 5,378,729, issued on Jan. 3, 1995 (“the
`’729patent”) (Ex. 1009).
`
`3 Kohn et al., Preparation and Anticonvulsant Activity of a Series of
`Functionalized α-Heteroatom-Substituted Amino Acids, 34 J. MED. CHEM.
`2444–52 (1991) (“Kohn 1991”) (Ex. 1012).
`
`4 Philippe LeGall, 2-Substituted-2-acetamido-N-benzylacetamides.
`Synthesis, Spectroscopic and Anticonvulsant Properties (Dec. 1987) (“the
`LeGall thesis”) (Ex. 1008).
`
`5 Silverman, The Organic Chemistry of Drug Design and DrugAction,
`Academic Press (1992) (“Silverman”) (Ex. 1013).
`
`
`
`3
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`1991 versus the ’301 patent) with secondary references (e.g., Silverman in
`
`the IPR). On that basis alone, the legal and factual considerations in the two
`
`proceedings differ significantly. In view of those differences, we are not
`
`persuaded that consolidation will simplify the issues to be decided,
`
`notwithstanding an overlap of certain documents and some aspects of an
`
`obviousness analysis in both cases. Motion 7–8.
`
`Petitioner suggests that a “high likelihood of prejudice to Petitioner
`
`and the public, versus the little-to-no likelihood of prejudice to Patent
`
`Owner, weighs in favor of consolidation.” Id. at 9. We disagree with that
`
`assessment. As an initial matter, Petitioner initiated both proceedings—
`
`Patent Owner did not. Moreover, Petitioner asks us to consolidate this IPR
`
`with the ex parte reexamination in a manner that benefits Petitioner and
`
`disadvantages Patent Owner.
`
`For example, as part of the requested “consolidated” IPR, Petitioner
`
`asks us: (i) to allow it to pursue two OTDP grounds in an IPR, a proceeding
`
`that otherwise is limited by statute (35 U.S.C. § 311(b)) to grounds based on
`
`35 U.S.C. §§ 102 or 103; (ii) to consider, again, the prior art status of a
`
`reference (the Le Gall thesis), which this panel already addressed when
`
`declining to institute review based on that reference; and (iii) to allow
`
`Petitioner to actively participate procedurally in the IPR, and any appeal of a
`
`final written decision in the case as needed, in a manner that it cannot do as a
`
`requester in the ex parte reexamination. See, e.g., Opposition 3–5
`
`(contrasting the examinational versus adjudicatory nature of the two
`
`proceedings); Motion 9 (asking us to place the reexamination on the one-
`
`year timeline of the IPR).
`
`
`
`
`
`4
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`
`Above and beyond those considerations, as noted by our colleagues,
`
`an ex parte reexamination proceeding differs in notable respects from an
`
`inter partes review, which is adjudicatory in nature. See Ford Motor Co. v.
`
`Signal IP, Inc., IPR2015-00860, slip op. at 3 (PTAB Nov. 17, 2015)
`
`(Paper 14). The two types of proceedings arise under different statutes and
`
`are governed by different rules and statutory deadlines. Id. Thus, “there is
`
`an inherent tension in attempting to unify proceedings that [] are intended to
`
`be distinct in type from one another.” Id. Considering that inherent tension,
`
`as well as the specific facts and circumstances at issue here, we decline to
`
`exercise our discretion to consolidate this IPR with the co-pending
`
`reexamination involving the ’551 patent.
`
`We are mindful of Petitioner’s concern regarding the prevention of
`
`“inconsistent outcomes” in the two proceedings. Motion 5. To address this
`
`concern, the parties shall file as an exhibit in this IPR a copy of any action,
`
`decision, or other substantive paper issued by the CRU involving the
`
`’551 patent, along with a non-argumentative one-page notice regarding the
`
`filing. In addition, either party may contact the Board, by initiating a
`
`conference call with the panel after conferring with the other party, in
`
`relation to any other matter in the reexamination that a party would like to
`
`bring to our attention. The parties also shall file any decision, order, or other
`
`substantive paper issued by the Board in this IPR in the corresponding co-
`
`pending reexamination.
`
`III. ORDER
`
`It is
`
`ORDERED that Petitioner’s Motion to Consolidate is denied;
`
`FURTHER ORDERED that the parties shall file as an exhibit in this
`
`
`
`5
`
`

`

`IPR2016-00204
`Patent RE38,551 E
`
`IPR a copy of any action, decision, or other substantive paper issued by the
`
`CRU involving the ’551 patent, and upon such filing, concurrently file as a
`
`paper in this proceeding a one-page notice stating that the filing occurred;
`
`and
`
`FURTHER ORDERED that the parties shall file any decision, order,
`
`or other substantive paper issued by the Board in this IPR in the
`
`corresponding co-pending reexamination.
`
`
`
`
`
`
`
`
`
`PETITIONER:
`
`Matthew Dowd
`Justin Crotty
`ANDREWS KURTH LLP
`matthewdowd@andrewskurth.com
`justincrotty@andrewskurth.com
`
`
`PATENT OWNER:
`
`Andrea Reister
`Jennifer Robbins
`Enrique Longton
`COVINGTON & BURLING LLP
`areister@cov.com
`jrobbins@cov.com
`rlongton@cov.com
`
`
`
`6
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket